Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-12-09
1999-11-30
Shah, Mukund J.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
435 71, 5462697, C09D491052, G01N 3353, C07D40310
Patent
active
059945540
ABSTRACT:
The present invention provides radiolabeled 5-{4-[2-(Methyl-pyridine-2-yl-amino)-ethoxy]-benzyl}-thiazolidine-2,4-dion e. In another aspect, the present invention provides a method for determining whether a compound does or does not interact directly with PPAR-gamma, comprising the step of specifically binding a radiolabeled compound of this invention to the ligand binding domain of PPAR-gamma.
REFERENCES:
patent: 5356913 (1994-10-01), Colca
J. Berger, et al., Gene, 66, 1988, pp. 1-10,"Secreted Placental Alkaline Phosphatase: A Powerful New Quantitative Indicator of Gene Expression in Eukaryotic Cells".
J.R. Colca and D.R. Morton, New Antibiotic Drugs, Chapter 24, 1990, pp. 255-261, "Antihyperglycaemic Thiazolidinediones: Ciglitazone and Its Analogues".
A.Y. Chang, et al., Diabetes, vol. 32, Sep. 1983, pp. 839-845, "Ciglitazone, a New Hypoglycemic Agent. II Effect on Glucose and Lipid Metabolisms and Insulin Binding in the Adipose Tissue of C57BL/6J-ob/ob and -+/? Mice".
C. Dreyer, et al., Cell, vol. 68, Mar. 6, 1992, pp. 879-887, "Control of the Peroxisomal .beta.-Oxidation Pathway by a Novel Family of Nuclear Hormone Receptors".
M. Gottlicher, et al., Proc. Natl. Acad. Sci. USA, vol. 89, May 1992, pp. 4653-4657, "Fatty Acids Activate a Chimera of the clofibric Acid-Activated Receptor and the Glucocorticoid Receptor".
R.A. Graves, et al., Molecular and Cellular Biology, vol. 12, No. 3, Mar. 1992, pp. 1202-1208, "Analysis of a Tissue-Specific Enhancer: ARF6 Regulates Adipogenic Gene Expression".
P.K.W. Harris and R.F. Kletzien, Molecular Pharmacology, 45, 1994, pp. 439-445, "Localization of a Pioglitazone Response Element in the Adipocyte Fatty Acid-Binding Protein Gene".
A. Hiragun, et al., Journal of Cellular Physiology, 134, 1988, pp. 124-130, "Preadipocyte Differentiation in Vitro: Identification of a Highly Active Adipogenic Agent".
A. Ibrahimi, et al., Molecular Pharmacology, 46, 1994, pp. 1070-1076, "Evidence for a Common Mechanism of Action for Fatty Acids and Thiazolidinedione Antidiabetic Agents on Gene Expression in Preadipose Cells".
I. Issemann and S. Green, Nature, vol. 347, Oct. 18, 1990, pp. 645-650, "Activation of a Member of the Steroid Hormone Receptor Superfamily by Peroxisome Proliferators".
H. Keller and W. Wahli, TEM, vol. 4, No. 9, 1993, pp. 291-296, "Peroxisome Proliferator-Activated Receptors".
R.F. Kletzien, et al., Molecular Pharmacology, 41, 1992, pp. 393-398, "Enhancement of Adipocyte Differentiation by an Insulin-Sensitizing Agent",
S.A. Kliewer, et al., Proc. Natl. Acad. Sci. USA, vol. 91, Jul 1994, pp. 7355-7359, "Differential Expression and Activation of a Family of Murine Peroxisome Proliferator-Activated Receptors".
B. Luckow and G. Schutz, Nucleic Acids Research, vol. 15 No. 13, 1987, p. 5490, "CAT Constructions with Multiple Unique Restriction Sites for the Functional Analysis of Eukaryotic Promoters and Regulatory Elements".
D.J. Mangelsdorf, et al., Cell, vol. 66, Aug. 9, 1991, pp. 555-561, "A Direct Repeat in the Cellular Retinol-Binding Protein Type II Gene Confers Differential Regulation by RXR and RAR".
J.J. Nolan, et al., The New England Journal of Medicine, vol. 331, No. 18, Nov. 3, 1994, pp. 1188-1193, "Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone".
M. Pfahl, et al., Methods in Enzymology, vol. 189, 1990, pp. 256-270, "Nuclear Retinoic Acid Receptors: Cloning, Analysis, and Function".
A. Schmidt, et al., Molecular Endocrinology, vol. 6, No. 4, 1992, pp. 1634-1641, "Identification of a New Member of the Steroid Hormone Receptor Superfamily That is Activated by a Peroxisome Proliferator and Fatty Acids".
R.L. Sparks, et al., Journal of Cellular Physiology, 146, 1991, pp. 101-109, "Antidiabetic AD4743 Enhances Adipocyte Differentiation of 3T3 T Mesenchymal Stem Cells".
P. Tontonoz, et al., Genes & Development, 8, 1994, pp. 1224-1234, "mPPAR.gamma.2: Tissue-Specific Regulator of an Adipocyte Enhancer".
Y. Zhu, et al., Journal of Biological Chemistry, vol. 268, No. 36, 1993, pp. 26817-26820, "Cloning of a New Member of the peroxisome Proliferator-Activated Receptor Gene Family from Mouse Liver".
Chawla, et al., Endocrinology, vol. 135, No. 2, 1994, pp. 798-800, "Peroxisome Proliferator-Activated Receptor (PPAR) .gamma.: Adipose-Predominant Expression and Introduction Early in Adipocyte Differentiation".
Tonotonoz, et al., Cell, vol. 79, Dec. 30, 1994, pp. 1147-1156, "Stimulation of Adipogenesis in Fibroblasts by PPAR.gamma.2, a Lipid-Activated Transcription Factor".
Tontonoz, et al., Nucleic Acids Res., 22(25), 1994, pp. 5628-5634, "Adipocyte-Specific Transcription Factor ARF6 is a Heterodimeric Complex of Two Nuclear Hormone Receptors, PPAR-.gamma. and RXRa".
Kletzien, et al., Mol. Pharmacol., 42(4), 1992, pp. 568-562, "Adipocyte Fatty Acid-Binding Protein: Regulation of Gene Expression in Vivo and in Vitro by an Insulin-Sensitizing Agent".
Cantello, et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 10, 1994, pp. 1181-1184, "The Synthesis of BRL 49653-A Novel and Potent Antihyperglycaemic Agent".
Ez-Zoubir Amri, et al., The Journal of Biological Chemistry, vol. 270, No. 5, 1995, pp. 2367-2371, "Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes".
Tontonoz, et al., Molecular and Cellular Biology, vol. 15, No. 1, Jan. 1995, pp. 351-357, "PPAR.gamma.2 Regulates Adipose Expression of the Phosphoenolpyruvate Carboxykinase Gene".
Ailhaud, et al., TEM, vol. 5, No. 3, 1994, pp. 132-136, "Hormonal Regulation of Adipose Differentiation".
Cantello, et al., The Journal of Biological Chemistry, vol. 270, no. 5, 1995, pp. 2367-2371, "Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes".
Nogardy. T., Med Chem A Biochemical Approach., pp. 104-105., 1988., Oxford Univ Press.
Sripada et al., (Title only)., International Conf. on Biomembranes., India., 1988.
Kliewer Steven Anthony
Lehmann Jurgen M.
Willson Timothy M.
Brink Robert H.
Glaxo Wellcome Inc.
Shah Mukund J.
Sripada Pavanaram K.
LandOfFree
Activators of the nuclear orphan receptor peroxisome proliferato does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Activators of the nuclear orphan receptor peroxisome proliferato, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activators of the nuclear orphan receptor peroxisome proliferato will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1674632